A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT03323151 · COMPLETED
Trial details
- NCT number
- NCT03323151
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2022-09-22
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.